We describe a family with autosomal dominant limb-girdle muscular dystrophy (LGMD) with the associated finding of early onset Paget disease of bone (PDB) and cardiomyopathy in a few individuals. Three similar associations of neuromuscular disease and Paget disease of bone have been previously reported. Familial PDB in association with dystrophia myotonica was reported in one family by Caughey et al.1 (MIM 16, 09002) . McBride3 found an association of PDB and a limb girdle type of muscular dystrophy in four of six siblings and Tucker et al. 4 identified a family with autosomal dominant amyotrophic lateral sclerosis (ALS, MIM 10,54002) and PDB.
Characterized by progressive proximal muscle dystrophy and weakness particularly of the shoulder and pelvic girdle with relative sparing of the other muscle groups, limb-girdle muscular dystrophies are a clinically and genetically heterogeneous group of neuromuscular diseases. At least 4 autosomal dominant and 8 autosomal recessive forms of LGMD have been reported. LGMDlA, located on chromosome 5q22-q31, is caused by a mutation in myotilin, a sarcomeric structural protein. [5] [6] [7] LGMDlC, caused by mutations in the muscle specific protein, caveolin-3, is located on chromosome 3~2 5 .~-~ The genes for LGMDlB (lq11-q21),1° LGMDlD (7q),11 and Edstrom myopathy, a related autosomal dominant myopathy that maps to 2q24-q31,12 are yet to be identified.
The genes for eight of the recessive forms of LGMD have been identified, the majority of which encode for components of the dystrophin-sarcoglycan complex ( Table 1) . None of these loci have been implicated in autosomal dominant neuromuscular or bone disease.
Autosomal dominant limb-girdle muscular dystrophy is associated with cardiomyopathy in LGMDlB and also in another family with dilated cardiomyopathy with conduction defect (CDCD3) located on chromosome 6q23.13 The loci for cardiomyopathy were therefore considered candidates for the disease in our family.
Paget disease of bone is characterized by an increase in bone remodeling and hypertrophy leading to abnormal bone structure, bone pain, and deformity.'WcKusickl~ reviewed 37 families with familial Paget disease of bone (PDB). Only one family exhibited male-to-male transmission suggesting the rarity of autosomal dominant families. Subsequently, two genetic loci have been linked to autosomal dominant PDB. The first to be identified, PDB1, was obtained with the HLA locus on chromosome 6p.I6 PDB2 was assigned to chromosome 18~21-2217 in a large Northern Irish family with PDB, and recently mutations in the gene TNFRSF1 1A were found in as- LGMDIA
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LGMD2G sociation.18 TNFRSFllA encodes for a receptor activator of nuclear factor-K B (RANK), which is essential for osteoclast formation. In addition to PDBl and PDB2, there is evidence for further genetic heterogeneity in Paget disease of bone.lY Linkage analysis with genetic markers for LGMD, cardiomyopathy and PDB excluded all dominant and recessive forms of LGMD as well as 6 loci for dominant dilated cardiomyopathy and 2 loci reported for dominant Paget disease of the bone (Table 2 ). These studies indicate that a unique locus exists for autosomal dominant LGMD in association with Paget disease of bone.
MATERIALS AND MnHODS

Clinical studies
Clinical studies were approved by the Springfield Committee for Research Involving Human Subjects, and consent was obtained from each subject prior to participation. Several members of this six-generation family ( Fig. 1) 
Cytogenetic analysis
High-resolution karyotype analysis at 800-850 band resolution performed on case 9 was normal excluding a deletion or other rearrangements as the cause of this unusual disorder (Genzyme Genetics, Santa Fe, NM, and Washington University, St. Louis, MO). 
DNA marker analysis
Peripheral venous blood was obtained by standard venipuncture. Genomic DNA was extracted by means of the PUREGENE DNA Isolation Kit (Gentra Systems; Minneapolis, MN). In cases where blood samples could not be obtained, buccal scraping were collected and processed using standard methods. Genotyping was performed to exclude/include linkage to known chromosome locations of the autosomal dominant and recessive forms of LGMD, dominant dilated cardiomyopathy, and PDB using microsatellite markers (Research Genetics, Inc., Huntsville, AL).
Linkage analysis
Linkage analysis was carried out on 23 members of the family (9 affected, 13 unaffected, and 1 unaffected spouse) with molecular markers for established loci of LGMD, Edstrom myopathy, PDB and cardiomyopathy ( Table 2 ). The amyotrophic lateral sclerosis locus on 21q was also excluded in view of its association with PDB.-' The power to detect linkage with the available pedigree was evaluated by simulating a marker locus with 5 alleles of equal frequency (heterozygosity = 0.8) completely linked to the disease locus (theta = 0.0) utilizing the SLINK program.I0-x The analysis was carried out under an autosomal dominant model. All individuals included in the analysis were above 20 years of age. Three age dependent liability classes were used to generate the pedigrees and to analyze them. It was assumed that there were no phenocopies and ratio of being wild type to being a disease allele carrier is as follows: 20-29 years old (1.1 1:l); 30-34 years old; (5:1), and 35 years and over (50:l). Two-point linkage analysis was carried out using the MLINK program of the FASTLINK computer package.12 The marker-allele frequencies were estimated from the data by means of both observed and reconstructed genotypes of founders within the pedigrees. Linkage was considered established to a locus if a positive LOD score of 3 was obtained and was considered excluded if a LOD score of -2 was obtained.
RESULTS
Clinical studies had a myocardial infarct at age 42 y and subsequently was diagnosed with cardiomyopathy.
Several members of this 6-generation family have been examined. The family includes several affected individuals; however, many are deceased prematurely from cardiomyopathy or other complications related to LGMDIPDB. The disorder in this family begins insidiously in the late 20s-30s in many individuals with back and hip pain, in addition to weakness and atrophy of the proximal arm and leg muscles. Nerve conduction studies were normal in most individuals. EMG shows muscle denervation. Bone X-rays of the spine, pelvis, shoulder, and skull indicate coarse trabeculation, cortical thickening, and spotty sclerosis consistent with the diagnosis of PDB. The disorder progresses to wheelchair confinement, quadriparesis, bedfastness, respiratory failure, cardiac failure, and death in the 40s-60s. Two individuals have had limited benefit from intravenous pamidronate several years ago. Two individuals received calcitonin with limited benefit, and one female is receiving alendronate with clinical improvement.
The following individuals were identified as affected from previous medical evaluations and/or clinical examination performed. Clinical data of the these affected individuals are summarized in Table 3 , and laboratory data including alkaline phosphatase, osteocalcin and CPK levels are summarized in Table 4 .
Case 1, the proband, a 48 y old female, developed back pain at the age of 34 y. X-rays of the spine and hip, and bone scan, revealed increased uptake in the L2 lumbar spine and the left ileum, suspicious for malignancy. A bone biopsy, however, revealed Paget disease and no evidence of malignancy. At age 34 y, she also noted proximal muscle weakness causing difficulty raising her arms. She had previously noticed tiredness and pain in her legs. At age 37 y, she had difficulty walking up the stairs, which she climbed by pulling herself up with her arms. She was diagnosed with LGMD at the age of 44 y. On -physical examination, she had weakness of the proximal muscles of the arms and legs. There was a lumbar lordosis and her gait was wide based. The reflexes, sensation, and muscle tone in her limbs was normal. Bone specific alkaline phosphatase levels were markedly elevated.
Case 2 is a 47 y old male who admitted to a history of weakness of arms and legs and muscle pain for the previous 5 years. An examination at age 47 y revealed minimal weakness of the proximal muscles. A subsequent muscle biopsy revealed variation in fiber size with fiber splitting, fiber nesting, and atrophic and hypertrophic fibers. The muscle was described as having mild myopathic changes. In addition, there was focal endomysial fibrosis, but no necrosis, regeneration, or degeneration ofmuscle fibers, features consistent with muscular dystrophy. An EMG at 45 y showed moderate fibrillation potentials, increased muscle fiber irritability, and small amplitude motor potentials, indicating a primary muscle disorder. Nerve conduction velocities (NCV) of the left upper and lower extremities were normal. All laboratory tests were within normal range and x-rays did not show evidence of Paget disease. He Case 3, a 49 y old female, has a 10 y history of back pain and occasional pain of the knees and calves. She complained of "Charlie horses" in the bottom of her feet, shoulders, and neck. Radiologic evaluation revealed sclerosis and lucencies seen in the right parietal bone with cortical thickening, which was also seen in the calvarium, mandible, mastoids, and sphenoid. Lumbar spine revealed Paget disease of L2 and L3, with coarse trabeculation of the T3 and T9 vertebral bodies. A bone scan revealed abnormal intense uptake in the calvarium, manubrium, left scapula, lower dorsal vertebral body, right pubic bone, and left distal femur consistent with Paget disease. At the age of 44 y, she received intravenous bisphosphonate for her PDB, which gave her temporary relief from the pain. She has also had an 8 y history ofconstant aching ofthe pectoral, shoulder, and thigh muscles. She is unable to raise her arms up and has difficulty climbing stairs. Physical evaluation reveals the typical weakness ofthe iliopsoas, quadriceps, and mild atrophy of the forearms bilaterally. She has a widebased gait. At 48 y, a muscle biopsy containing atrophic fibers revealed muscle with no pathologic diagnosis. An EMG showed small amplitude motor units in the biceps and vastus lateralis consistent with a myopathic process. She @currently on disability for her muscular dystrophy.
Case 4 is a 57 y old male currently on disability from PDB and LGMD. He is unable to raise his arms and walks slowly with the assistance of a cane. He has moderately severe pain in his thoracic and lumbar spine. He is a smoker and has respiratory difficulties. Skeletal X-rays and bone scan reveals active PDB in the skull, shoulder, hip, and lumbar and vertebral spine. An echocardiogram was normal. Physical examination reveals tenderness of the spine and hip in addition to features of LGMD. Treatment includes bisphosphonates and calcitonin. An EMG showed small amplitude motor potentials in the leg muscles suggestive of a primary muscle disorder and focal abnormalities of upper extremity nerves. The NCV were normal.
Case 5, the 33-year-old son of case 4, has had back and right hip pain for approximately 18 months. X-ray studies suggested PDB in the hip, skull, and spine. Examination revealed an individual who walked slowly with a limp because of back pain. He had moderately severe tenderness of the back over the thoracic and lumbar spine. Bone specific alkaline phosphatase and osteocalcin levels were markedly elevated. He is being treated with analgesics and calcitonin. He did not have evidence of muscular dystrophy clinically, and his CPK was normal.
Case 6 was evaluated after his death at age 50 y. Diagnosis of LGMD, PDB, and cardiomyopathy was at 38 y. He had a prior history of diabetes mellitus, stroke, obesity, and coronary artery disease for which he had a balloon angioplasty. Medical records indicate that his alkaline phosphatase levels were consistently elevated. Physical examination revealed left-sided hemiparesis from the stroke, shoulder and pelvic muscle atrophy. He had not received any prior treatment for Paget disease of bone. He had been bedridden for several months prior to death from cardiac failure.
Case 7, a 45 y female, was recently diagnosed with PDB because ofback and shoulder pain. MRI ofthe back showed Paget disease in the L5 vertebral body. Total alkaline phosphatase levels were elevated. On examination, she had proximal muscle weakness ofthe arms and hips and wasting ofthe small muscles of the hands consistent with LGMD. She is currently receiving treatment with Fosamax (alendronate sodium), cyclobenzaprine, and analgesics.
Case 8, age 46 y, was diagnosed with LGMD at age 40 y when he noticed muscle weakness and atrophy of bilateral upper arms. He has weakness in his legs and upper arms and has difficulty getting up from a squatting position. Muscle biopsy reveals atrophic fibers and end stage myopathy. EMG shows mild spontaneous activity and small amplitude motor potentials consistent with a primary muscle disorder. Nerve conduction studies were normal. CPK levels were highly elevated and alkaline phosphatase levels were normal. X-rays did not reveal definite evidence of PDB. His father had a history of Paget disease, and died at 73 y due to respiratory compromise related to LGMD.
Case 9 first noticed muscular weakness at age 50 y. The disease progressed to cause severe weakness of the muscles, making it difficult for him to get out of a chair. He was wheelchair bound for the last year and required supplemental 02. Additionally, he had peripheral neuropathy causing loss of sensation in his extremities. Deep tendon reflexes were absent in the leg. He reported no disability from PDB, which was discovered at 37 y, after a spine x-ray was performed to investigate a fall from a ladder. A bone scan revealed intense activity in the right clavicle, L3 vertebra, right hemipelvis, sacrum, and left acetabulum. Laboratory results showed his total alkaline phosphatase was greatly elevated. His CPK was borderline elevated. His echocardiogram was grossly normal. A series of muscle biopsies in case 9 shows a progression of the disorder. At 40 y, there were minimal and nonspecific changes with occasional atrophic fibers favoring a "lower motor neuron disease" rather than muscular dystrophy. Aside from these minor variations, the biopsy was reported as within normal limits. At 55 y, degenerating and regenerating fibers, along with fiber size variation was noted. Small vacuolated fibers were also seen scattered throughout the muscle (Fig. 2) . A final biopsy at 63 y revealed severe, chronic myopathy with vacuolar changes, including rimmed vacuoles, and atrophic fibers in large groups of whole fascicles NCV studies suggested mild carpal tunnel syndrome. EMG showed mild myopathic changes. He died at age 65 y from respiratory failure.
Cases 10 and 11 were not examined. Medical information was obtained from medical records. Normal Lumbar spine and pelvis 'NT, not tested; CPK, creatine phosphokinase. Case 10 died at the age of 59 y after being bedridden for the preceding three years. Symptoms of the LGMD began with progressive weakness of both his upper and lower extremities at 51 y. He had difficulty walking up the stairs and experienced aching and weakness of his trunk muscles and lower extremities, which affected the thighs more than the lower legs. He demonstrated winging of the scapulae bilaterally. Alkaline phosphatase levels were elevated, while CPK levels were within the normal range. A muscle biopsy was performed and adipose tissue was seen between some of the muscle bundles with no specific findings of intrinsic muscle disease.
Case 11 died at age 61 y of congestive heart failure and PDB. He had a history of diabetes mellitus, pulmonary obstructive disease, chronic bronchitis and bronchial asthma, and Paget disease involving the lumbar spine, pelvis, and proximal portions of both femurs. His alkaline phosphatase levels were greatly elevated. He demonstrated winging of the scapulae and weakness in the arms. He also experienced intermittent hypertension and mild coronary insufficiency. His EKG showed slight ST depression in V5 and V6 and his alkaline phosphatase levels were greatly elevated.
Laboratory evaluation
Paget disease of bone
All individuals showing radiologic evidence of PDB had corresponding elevated alkaline phosphatase levels ( Table 4 ). The mean value of total alkaline phosphatase in affected individuals was 747.7 IUIliter (normal range 30-130 Ulliter) with a range of 88-1724 IUIliter. Cases 2 and 8 were not clinically diagnosed with PDB and had normal akaline phosphatase levels. Osteocalcin was elevated only in the youngest individual, 33 y, to a value of 54.6 ng/mL (normal range 8-52 ng1mL). All other individuals had normal levels with a mean of 20.0 ng/mL. Additionally, urine pyridolinium cross link studies were obtained in all individuals, but results were not helpful in distinguishing affected from unaffected individuals (data not shown).
~e n e t h y Medicine 
Limb-girdle m~iscz~lar dystrophy
All individuals diagnosed with LGMD were characterized by severe muscle weakness particularly in the arms, legs, shoulder, and pelvic girdle. Laboratory evaluations of the CPK were not found helpful in screening for LGMD in the majority of individuals. Only 211 1 individuals had elevations of CPK (normal, .
Muscle biopsy
Six out of eleven individuals had muscle biopsies. Histology in 5 individuals showed nonspecific myopathic changes ( Table  4) . A series of muscle biopsies in case 9 shows a progression of the disorder. At age 40 y, the muscle was almost normal. At 55 y, generating and regenerating fibers were present with fiber size variation and small vacuolated fibers (Fig. 2) . At age 63 y, he had severe, chronic myopathy with vacuolar changes, rimmed vacuoles, and atrophic fibers in large groups of whole fascicles.
Electromyographic (EMG) studies
EMG was performed on 5 affected individuals. Overall, the studies revealed spontaneous fibrillation, small polyphasic motor units and mild membrane irritability consistent with a myopathic process as seen in LGMD. One individual (case 9) had additional neuropathic changes clinically and on EMG.
Linkage a~zalysis
Linkage analysis was carried out on 23 members of the family ( 9 affected, 13 unaffected, 1 spouse) with molecular markers for established loci of autosomal dominant LGMD and autosomal dominant PDB. Linkage to the autosomal recessive forms of LGMD as well as 6 loci for dominant cardiomyopathy was also examined for this pedigree. Sufficiently negative LOD scores were obtained for all markers evaluated (Table 2) , thus excluding all the candidate genes from linkage.
DISCUSSION
Limb-girdle muscular dystrophy associated with Paget disease is an unusual disorder. Paget disease of bone affects approximately 2-3% of the population > 50 y, and autosomal dominant LGMD is extremely rare; therefore, the co-occurrence of both disorders by chance in 811 1 individuals in our family is unlikely."
Three reports of families with Paget disease of bone and neuromuscular disease have been described previously (Table 5 ). McBride3 reported a family of 6 siblings: three brothers and one sister were diagnosed with widespread Paget disease of bone and muscular dystrophy, one sister had localized Paget disease in one lumbar vertebra, and one brother was unaffected. Possible mild phenotype in the mother was reported so the inheritance pattern was difficult to deduce.
Caughey et a1.l reported three brothers with dytrophia myotonica, two of whom had PDB. Individuals had typical features of dystrophia myotonica including stiff muscles, inability to relax the grip, myotonia of the tongue and hand muscles, hypertrophy of the biceps and forearms, muscle size disproportionate muscle strength, and weakness of the abdominal and sternomastoid muscles. One ofthe brothers exhibiting Paget of the vertebrae and pelvis had a neoplastic process compressing the spinal cord. The parents were unaffected, possibly suggesting autosomal recessive inheritance.
Tucker et al.4 described a family with lower motor neuron degeneration and "Paget-like bone disease." In the nine individuals pelvic and shoulder muscle weakness and atrophy started at 35-40 y, with death occurring before the age of 60 y. Of the nine individuals, seven were known to exhibit signs of Paget disease. The reported features were very similar to our family; however, there was no instance of male-to-male transmission in the family possibly suggesting an X-linked mode of inheritance. An isolated case report of 53 y old male with PDB and lower motor neuron was reported by Varelas and K a~a t i *~ who estimated that the combined incidence of PDB and ALS ranges between 0.012 and 0.108/100,000.
Cardiac failure and cardiomyopathy occurs in the latter stages of the disease in some individuals in our family. Two of these individuals are heavy smokers and have coronary artery disease; therefore, the significance of cardiomyopathy is uncertain in them. Messina et al.13 reported a four-generation family with conduction defect (CDCD3) and muscle weakness, which they mapped to 6q23. Van der Kooi et al.1° identified a family demonstrating LGMDlB with related cardiac abnormalities in 62.5% of the affected individuals and sudden cardiac death at approximately 50 y. Paget disease of bone has been known to lead to high output congestive heart failure due to the increased vascularity of abnormal bone.25 Linkage analysis was undertaken for candidate loci for cardiomyopathy; however, they were excluded.
Pharmacological treatment of PDB has included calcitonin, a peptide hormone that inhibits osteoclast activity. Bisphosphonates, are more successful in the management of Paget disease, induce marked and prolonged inhibition of bone resorption through a direct effect on mature osteoclasts. Disruption of cellular metabolism and induction of osteoclast apoptosis are the most likely mechanisms.26 Etidronate was the first bisphosphonate to be used in the management of Paget disease.27 Introduction of additional bisphosphonates include pamidronate, tiludronate, alendronate, and risedronate, respectively, with each increasing in potency and efficacy.
Therapy in the muscular dystrophies has been less successful and has included coenzyme Q,28 steroids," myoblast transfer30 and gene therapy clinical trials in the autosomal recessive types of LGMD.3
In conclusion, the results from our linkage analysis confirm that autosomal dominant LGMD with associated PDB is genetically distinct. Discovery of new genes involved in dominant LGMD should provide insight into the pathogenesis of muscle disease as they have done in the autosomal recessive types.33 It is possible that a biochemical overlap exists between the biological processes of bone and muscle maintenance and regeneration that could potentially be influenced by a single gene mutation. Elucidation of the gene responsible for LGMD associated with PDB may help unravel the biochemical nature of this unique disorder, eventually resulting in the development of novel treatment protocols including gene therapy.
